Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Avanos Medical stock price, quote, forecast and news

AVNS
US05350V1061
A2JNRG

Price

24.03
Today +/-
+0.23
Today %
+1.09 %
P

Avanos Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Avanos Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Avanos Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Avanos Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Avanos Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Avanos Medical Stock Price History

DateAvanos Medical Price
9/30/202424.03 undefined
9/27/202423.77 undefined
9/26/202423.49 undefined
9/25/202423.40 undefined
9/24/202423.73 undefined
9/23/202423.71 undefined
9/20/202424.14 undefined
9/19/202424.69 undefined
9/18/202424.21 undefined
9/17/202424.15 undefined
9/16/202424.20 undefined
9/13/202424.00 undefined
9/12/202423.54 undefined
9/11/202423.51 undefined
9/10/202423.91 undefined
9/9/202423.91 undefined
9/6/202423.72 undefined
9/5/202424.13 undefined
9/4/202423.91 undefined
9/3/202424.08 undefined

Avanos Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Avanos Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Avanos Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Avanos Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Avanos Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Avanos Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Avanos Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Avanos Medical’s growth potential.

Avanos Medical Revenue, EBIT and net profit per share

DateAvanos Medical RevenueAvanos Medical EBITAvanos Medical Net Income
2027e846.19 M undefined172.48 M undefined104.99 M undefined
2026e782.44 M undefined144.64 M undefined95.14 M undefined
2025e744.43 M undefined128.78 M undefined85.21 M undefined
2024e709.14 M undefined100.73 M undefined65.05 M undefined
2023673.3 M undefined4.2 M undefined-61.8 M undefined
2022820 M undefined76 M undefined50.5 M undefined
2021744.6 M undefined16.7 M undefined5.2 M undefined
2020714.8 M undefined-46.1 M undefined-27.2 M undefined
2019697.6 M undefined-37.9 M undefined-45.9 M undefined
2018652.3 M undefined31.8 M undefined57.5 M undefined
2017611.6 M undefined-43.1 M undefined79.3 M undefined
2016566.2 M undefined-107.1 M undefined39.8 M undefined
2015509 M undefined-135.7 M undefined-426.3 M undefined
20141.67 B undefined94.3 M undefined27.1 M undefined
20131.68 B undefined225.3 M undefined154.6 M undefined
20121.68 B undefined228 M undefined152.6 M undefined
20111.66 B undefined210.7 M undefined142.4 M undefined

Avanos Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024e2025e2026e2027e
1.661.681.681.670.510.570.610.650.70.710.740.820.670.710.740.780.85
-1.51-0.42-0.30-69.5611.207.956.716.902.444.2010.22-17.935.354.945.118.18
35.5635.7536.4932.7850.4952.4754.9959.8257.6852.2448.9254.8856.32----
5906026125482572973363904023733644503790000
21022822594-135-107-4331-37-4616764100128144172
12.6613.5413.425.62-26.52-18.90-7.044.75-5.31-6.442.159.270.5914.1017.2018.4120.33
14215215427-426397957-45-27550-61658595104
-7.041.32-82.47-1,677.78-109.15102.56-27.85-178.95-40.00-118.52900.00-222.00-206.5630.7711.769.47
46.546.546.546.546.646.646.847.247.647.848.647.346.60000
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The Avanos Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Avanos Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
201220132014201520162017201820192020202120222023
                       
47.944.1149129.5113.7219.7384.5205.3111.5118.5127.787.7
183.7203.3233.9224.7190.1203150.5163.8108.6118.2155.7128.7
0000000059.31312.214.1
301.7285.6283.1303.2272.591.1121.4145.9168.9159.3190.3163.2
60.452.118.918.617.2646.957.223.518.918.613.993.3
0.590.590.680.680.591.160.710.540.470.430.50.49
325.7324.9277.8279.5260.8109.9154.1248.5223.6206.7194.5144
000000000000
000000000000
176.8141.2108.382.6169.8148.9168.2184.3157.7141.2251239.5
1.431.431.430.951.030.760.780.80.80.80.820.8
3.92.730.516.918.711.713.927.421.826.522.225.8
1.941.91.841.321.481.041.121.261.211.181.291.21
2.532.482.5322.072.21.831.81.671.61.791.69
                       
00500500500500500500500500500500
001.51.521.531.551.581.591.611.631.651.66
2.052.10.01-0.42-0.38-0.3-0.24-0.29-0.32-0.3-0.25-0.31
10.1-19.6-19.1-43.2-1.4-31.30.6-0.5-0.400.30
0000-48.70-34.3-31.5-27.7-33.8-36.1-27
2.062.081.491.061.11.221.31.271.271.291.361.32
102.2118.5168.7163.2173.1171.2169.98367.656.467.956.3
181180175.6152151.3144.994.4129.598.782.8111.7106
007.80033.90000063.7
75.911.93.9000000000
0000039.800006.28.6
359.1310.4356315.2324.4389.8264.3212.5166.3139.2185.8234.6
00632.3578.1579541.1247.7248.1180130226.3159.4
96.490.527.923.835.817.84.405.711.925.423.8
23420.227.830.131.819.873.864.351.958.238.3
119.494.5680.4629.7644.9590.7271.9321.9250193.8309.9221.5
0.480.41.040.940.970.980.540.530.420.330.50.46
2.532.482.5322.072.21.841.811.681.621.851.78
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Avanos Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Avanos Medical's financial health and stability.

Assets

Avanos Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Avanos Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Avanos Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Avanos Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2011201220132014201520162017201820192020202120222023
14215215427-426397957-45-27550-61
51576985656559333642384746
3-110-350000-1713-30-22
-696-311-2265-10-150-59-6726-24-18
14210674953328-7521473432104
00003229282016163814
000874329219680-45-223
13920222314797188144-145-74-2879032
-39-40-49-78-70-29-43-49-50-20-21-19-17
-39-40-50-70-62-200-43639-108-24-21-13521
00-177-1710688-57-40-11639
0000000000000
11-24-63624-5100-3390-69-50103-64
00000021612-5-43-17
-115-133-18029-50-12-3241-70-5556-94
-126.00-109.00-116.00-595.00----1.00--2.00--2.00-11.00
0000000000000
-1427-3104-19-15106164-179-9379-40
99.9161.8174.869.427.2159.7101-194.7-125.1-22.766.371.614.6
0000000000000

Avanos Medical stock margins

The Avanos Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Avanos Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Avanos Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Avanos Medical's sales revenue. A higher gross margin percentage indicates that the Avanos Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Avanos Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Avanos Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Avanos Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Avanos Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Avanos Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Avanos Medical Margin History

Avanos Medical Gross marginAvanos Medical Profit marginAvanos Medical EBIT marginAvanos Medical Profit margin
2027e56.39 %20.38 %12.41 %
2026e56.39 %18.49 %12.16 %
2025e56.39 %17.3 %11.45 %
2024e56.39 %14.2 %9.17 %
202356.39 %0.62 %-9.18 %
202254.88 %9.27 %6.16 %
202148.93 %2.24 %0.7 %
202052.22 %-6.45 %-3.81 %
201957.65 %-5.43 %-6.58 %
201859.93 %4.88 %8.81 %
201755.09 %-7.05 %12.97 %
201652.49 %-18.92 %7.03 %
201550.65 %-26.66 %-83.75 %
201432.81 %5.64 %1.62 %
201336.49 %13.43 %9.22 %
201235.78 %13.54 %9.06 %
201135.59 %12.69 %8.58 %

Avanos Medical Stock Sales Revenue, EBIT, Earnings per Share

The Avanos Medical earnings per share therefore indicates how much revenue Avanos Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avanos Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avanos Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avanos Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avanos Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Avanos Medical Revenue, EBIT and net profit per share

DateAvanos Medical Sales per ShareAvanos Medical EBIT per shareAvanos Medical Earnings per Share
2027e18.42 undefined0 undefined2.28 undefined
2026e17.03 undefined0 undefined2.07 undefined
2025e16.2 undefined0 undefined1.85 undefined
2024e15.43 undefined0 undefined1.42 undefined
202314.45 undefined0.09 undefined-1.33 undefined
202217.34 undefined1.61 undefined1.07 undefined
202115.32 undefined0.34 undefined0.11 undefined
202014.95 undefined-0.96 undefined-0.57 undefined
201914.66 undefined-0.8 undefined-0.96 undefined
201813.82 undefined0.67 undefined1.22 undefined
201713.07 undefined-0.92 undefined1.69 undefined
201612.15 undefined-2.3 undefined0.85 undefined
201510.92 undefined-2.91 undefined-9.15 undefined
201435.96 undefined2.03 undefined0.58 undefined
201336.08 undefined4.85 undefined3.32 undefined
201236.22 undefined4.9 undefined3.28 undefined
201135.7 undefined4.53 undefined3.06 undefined

Avanos Medical business model

Avanos Medical Inc is a global medical technology company specializing in products used in pain management, wound care, and anesthesia. The company's history dates back to the 1920s when it was founded under the name Kimble Glass. Over the years, the company has expanded into new markets, including the field of medical technology. Today, Avanos Medical Inc is a leading provider of medical devices and solutions. The company is divided into four core areas: pain management, anesthesia, interventional medicine, and wound care. Each of these areas specializes in the development and manufacture of specific products and solutions. In the field of pain management, Avanos Medical Inc offers a range of products that effectively and safely treat pain. These include patient-controlled analgesia (PCA) devices and nerve stimulation devices. In anesthesia, the company provides products that help safely sedate and intubate patients, as well as relieve their pain. These include anesthesia masks, laryngeal tubes, breathing bags, and anesthetics. In the field of interventional medicine, the company offers innovative solutions for minimally invasive procedures. These include catheter-based systems for pain management and diagnostics, as well as endoscopes for diagnostics and therapy in gastroenterology. Finally, Avanos Medical Inc also offers a wide range of wound care solutions, ranging from skin repair materials to wound dressings for various applications. Avanos Medical Inc's business model is based on an inclusive and integrative approach. The company works closely with doctors, hospitals, clinics, and other medical facilities to develop the most innovative products and solutions for the best patient care. Avanos Medical Inc aims to provide groundbreaking medical solutions for healthcare providers and their patients by maintaining a strong pipeline of product candidates while promoting an innovation culture. The company is committed to developing its products to be user-friendly, affordable, and of the highest quality. This aligns with Avanos Medical Inc's pursuit of a better patient experience and improved healthcare. Overall, Avanos Medical Inc is a leading company in the medical technology industry, focused on meeting the needs of patients and healthcare providers. With its innovative products and solutions, the company strives to set the standard for medical devices and services worldwide. Avanos Medical is one of the most popular companies on Eulerpool.com.

Avanos Medical SWOT Analysis

Strengths

Avanos Medical Inc has a strong market presence and brand reputation in the medical supplies industry. The company offers a wide range of innovative and high-quality products that cater to various medical needs. This diversity gives them a competitive edge over their rivals.

They have a robust manufacturing and distribution network, allowing them to efficiently reach their customers worldwide. This enables Avanos to respond quickly to market demands and provide timely solutions to healthcare providers.

Weaknesses

Avanos Medical Inc faces challenges related to dependency on a few key suppliers, which may cause disruptions in the supply chain and impact their ability to deliver products on time. This vulnerability must be addressed to ensure smooth operations.

The company also needs to enhance its research and development capabilities to stay ahead of rapidly evolving healthcare trends. Investing more in innovation can lead to a wider product portfolio and better market positioning.

Opportunities

Avanos can seize the opportunity to expand its market reach by targeting emerging economies where the demand for medical supplies is growing. By developing strategic partnerships and distribution agreements, the company can tap into new customer segments and increase its revenue streams.

The increasing focus on minimally invasive procedures and patient comfort opens avenues for Avanos to develop specialized products that cater to these specific needs. By addressing these trends, they can gain a competitive advantage over traditional medical device manufacturers.

Threats

The highly competitive nature of the medical supplies industry poses a threat to Avanos. They need to continuously invest in research and development, marketing, and branding to stay ahead of their competitors.

Evolving regulations and changing reimbursement policies in the healthcare sector can also pose challenges for Avanos. Adapting to these regulatory changes and effectively navigating through them is crucial for the long-term success of the company.

Avanos Medical Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Avanos Medical Revenue by Segment

Segmente2017201620152014
Chronic care----
Pain management----
Chronic care----
Pain management----
Chronic Care:----
Pain Management:----
S&IP-1.01 B USD1.03 B USD1.14 B USD
Medical Devices611.6 M USD567.3 M USD509.5 M USD501.7 M USD

Avanos Medical Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Avanos Medical Revenue by Segment

DateDomesticUnited States
2022-560.7 M USD
2021-521.6 M USD
2020-482 M USD
2019-481 M USD
2018457 M USD-
2017-467 M USD
2016-1.1 B USD
2015-1.1 B USD
2014-1.1 B USD

Avanos Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Avanos Medical historical P/E ratio, EBIT, and P/S ratio.

Avanos Medical shares outstanding

The number of shares was Avanos Medical in 2023 — This indicates how many shares 46.6 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avanos Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avanos Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avanos Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avanos Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Avanos Medical.

Avanos Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.29 0.29  (-0.92 %)2024 Q2
3/31/20240.22 0.19  (-13.24 %)2024 Q1
12/31/20230.37 0.32  (-14.44 %)2023 Q4
9/30/20230.29 0.42  (47.06 %)2023 Q3
6/30/20230.3 0.37  (21.71 %)2023 Q2
3/31/20230.28 0.27  (-3.47 %)2023 Q1
12/31/20220.5 0.6  (20.05 %)2022 Q4
9/30/20220.36 0.38  (5.67 %)2022 Q3
6/30/20220.39 0.41  (5.24 %)2022 Q2
3/31/20220.27 0.26  (-1.96 %)2022 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Avanos Medical stock

Eulerpool World ESG Rating (EESG©)

53/ 100

🌱 Environment

37

👫 Social

99

🏛️ Governance

23

Environment

Scope 1 - Direct Emissions
1,611.34
Scope 2 - Indirect emissions from purchased energy
13,259.54
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
14,870.88
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
✅
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees44
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Avanos Medical list of shareholders

%
Name
Stocks
Change
Date
6.90197 % RGM Capital, LLC3,171,455219,76412/31/2023
6.21161 % Dimensional Fund Advisors, L.P.2,854,235-55,75012/31/2023
4.68137 % Westwood Management Corp. (Texas)2,151,09141,81812/31/2023
4.27176 % State Street Global Advisors (US)1,962,876-26,88012/31/2023
4.03889 % T. Rowe Price Investment Management, Inc.1,855,868228,78512/31/2023
3.59807 % Paradice Investment Management LLC1,653,312-619,44612/31/2023
2.65552 % William Blair Investment Management, LLC1,220,210125,53512/31/2023
2.15622 % Geode Capital Management, L.L.C.990,78543,03912/31/2023
15.15396 % BlackRock Institutional Trust Company, N.A.6,963,244285,03112/31/2023
11.77380 % The Vanguard Group, Inc.5,410,059-52,38612/31/2023
1
2
3
4
5
...
10

Avanos Medical Executives and Management Board

Mr. Joseph Woody57
Avanos Medical Chief Executive Officer, Director (since 2017)
Compensation 6.87 M
Mr. Michael Greiner50
Avanos Medical Chief Financial Officer, Senior Vice President, Chief Transformation Officer
Compensation 2.64 M
Ms. Mojirade James56
Avanos Medical Senior Vice President, General Counsel, Secretary
Compensation 1.88 M
Mr. Kerr Holbrook56
Avanos Medical Senior Vice President, Chief Commercial Officer
Compensation 1.44 M
Mr. Gary Blackford65
Avanos Medical Independent Non-Executive Chairman of the Board
Compensation 384,375
1
2

Avanos Medical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
McKesson Stock
McKesson
SupplierCustomer0,21-0,58-0,58-0,33-0,53-0,43
Owens & Minor Stock
Owens & Minor
SupplierCustomer-0,020,330,820,750,49-0,07
1

Most common questions regarding Avanos Medical

What values and corporate philosophy does Avanos Medical represent?

Avanos Medical Inc represents a strong set of values and a dedicated corporate philosophy. The company is committed to improving patients' lives through innovative medical solutions. Avanos prioritizes patient-centered care, ensuring their products and services meet the highest standards of quality and safety. The company values integrity, empathy, and collaboration, fostering a culture of trust and respect among its employees and stakeholders. Avanos is driven by a passion for advancing healthcare and delivering positive patient outcomes. Through continuous innovation and a focus on customer satisfaction, Avanos strives to be a leading provider of healthcare solutions worldwide.

In which countries and regions is Avanos Medical primarily present?

Avanos Medical Inc is primarily present in various countries and regions worldwide. With a global presence, the company serves customers across North America, Europe, Asia Pacific, Latin America, and the Middle East. Its products and services have gained popularity in countries like the United States, Canada, Germany, France, Italy, United Kingdom, China, Japan, Australia, Brazil, Mexico, Saudi Arabia, and the United Arab Emirates. Avanos Medical Inc's extensive geographical reach highlights its commitment to delivering healthcare solutions internationally, making it a trusted and recognized name in the medical industry around the globe.

What significant milestones has the company Avanos Medical achieved?

Avanos Medical Inc has achieved several significant milestones throughout its history. The company has successfully expanded its product portfolio, introduced innovative medical devices, and demonstrated consistent revenue growth. Avanos Medical Inc has successfully established a strong global presence, with a diverse customer base and strategic partnerships. Additionally, the company has received numerous accolades and recognitions for its contributions to the healthcare industry. Avanos Medical Inc continues to be a leader in the medical technology sector, driving advancements and delivering high-quality solutions to improve patient outcomes.

What is the history and background of the company Avanos Medical?

Avanos Medical Inc, formerly known as Halyard Health, is a leading medical device company that specializes in the development and manufacturing of innovative healthcare solutions. Established in 2014, Avanos has a rich history with roots tracing back to Kimberly-Clark Corporation. With a commitment to improving patient outcomes and enhancing healthcare standards, Avanos prides itself on delivering high-quality, evidence-based products and technologies. The company focuses on four key areas: surgical pain management, interventional pain management, chronic care solutions, and digestive health. Avanos strives to continually advance medical science and provide healthcare professionals with cutting-edge tools to improve patient care.

Who are the main competitors of Avanos Medical in the market?

The main competitors of Avanos Medical Inc in the market include companies such as Medtronic, Johnson & Johnson, Becton Dickinson, and Boston Scientific. Avanos Medical Inc faces competition from these industry leaders in the medical device and healthcare sector. It engages in continuous research and development to stay competitive and maintain its market position against these formidable rivals.

In which industries is Avanos Medical primarily active?

Avanos Medical Inc operates primarily in the healthcare industry. As a global medical technology company, it focuses on developing and providing innovative solutions in the fields of medical devices and healthcare products. Avanos Medical Inc specializes in areas such as pain management, respiratory health, and surgical procedure support. With its commitment to advancing patient care, the company offers a wide range of products and services to cater to the needs of healthcare professionals and patients worldwide. Avanos Medical Inc's expertise lies in delivering effective and safe healthcare solutions for improved patient outcomes.

What is the business model of Avanos Medical?

Avanos Medical Inc's business model focuses on providing innovative medical solutions to healthcare providers worldwide. As a global medical technology company, Avanos develops and manufactures a wide range of products, including surgical and anesthesia products, respiratory equipment, and pain management solutions. By leveraging its expertise and advanced technologies, Avanos aims to improve patient outcomes and enhance healthcare efficiency. The company continuously invests in research and development to develop groundbreaking solutions that address unmet medical needs. Avanos Medical Inc is committed to delivering high-quality products and services that positively impact patient care across various medical specialties.

What is the P/E ratio of Avanos Medical 2024?

The Avanos Medical P/E ratio is 17.21.

What is the P/S ratio of Avanos Medical 2024?

The Avanos Medical P/S ratio is 1.58.

What is the AlleAktien quality score of Avanos Medical?

The AlleAktien quality score for Avanos Medical is 1/10.

What is the revenue of Avanos Medical 2024?

The expected Avanos Medical revenue is 709.14 M USD.

How high is the profit of Avanos Medical 2024?

The expected Avanos Medical profit is 65.05 M USD.

What is the business model of Avanos Medical

Avanos Medical Inc is a leading company in the medical technology industry, specializing in innovative products for pain relief, wound care, and respiratory therapy. The company is headquartered in Alpharetta, Georgia, USA and employs over 4,000 employees worldwide. Avanos Medical is divided into three business segments: Interventional Specialties, Pain Management, and Wound Care. Interventional Specialties: In this business segment, Avanos Medical offers products used in minimally invasive procedures for pain relief. An example of this is soft tissue needles used for injecting pain medication directly into the affected tissue. Another example is catheters for pain relief that can be inserted directly into the spine or specific nerves. Pain Management: This business segment focuses on the development of products for pain relief and treatment. Avanos Medical offers products such as patch pumps for continuous pain therapy, enabling controlled and effective pain management. Another example is opioid-sparing technology, which combines medications to reduce the dosage of opioids and thus lower the risk of side effects. Wound Care: In the wound care business segment, Avanos Medical focuses on developing products that accelerate wound healing and facilitate the treatment of chronic wounds. For example, the company offers hydrocolloid dressings that create a moist wound environment, promoting faster healing. Another product is the Negative-Pressure Wound Therapy System (NPWT), which helps clean wounds and remove wound exudate to promote healing. Overall, Avanos Medical offers a wide range of products that contribute to pain relief, faster wound healing, and improved quality of life for patients. The company is committed to continuously expanding and improving its product offerings to meet the needs of patients and healthcare professionals. In addition to products, Avanos Medical also provides training and support for healthcare professionals to ensure proper and effective use of their products. The company has also formed partnerships with other medical companies to drive innovation and the development of new products. Overall, Avanos Medical's business model is focused on the development and distribution of high-quality medical products that improve the lives of patients. The company has established itself as a key player in the medical technology industry and is expected to continue expanding in the future.

What is the Avanos Medical dividend?

Avanos Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Avanos Medical pay dividends?

The dividend cannot currently be calculated for Avanos Medical or the company does not pay out a dividend.

What is the Avanos Medical ISIN?

The ISIN of Avanos Medical is US05350V1061.

What is the Avanos Medical WKN?

The WKN of Avanos Medical is A2JNRG.

What is the Avanos Medical ticker?

The ticker of Avanos Medical is AVNS.

How much dividend does Avanos Medical pay?

Over the past 12 months, Avanos Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avanos Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Avanos Medical?

The current dividend yield of Avanos Medical is .

When does Avanos Medical pay dividends?

Avanos Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avanos Medical?

Avanos Medical paid dividends every year for the past 0 years.

What is the dividend of Avanos Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avanos Medical located?

Avanos Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avanos Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avanos Medical from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Avanos Medical pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Avanos Medical in the year 2023?

In the year 2023, Avanos Medical distributed 0 USD as dividends.

In which currency does Avanos Medical pay out the dividend?

The dividends of Avanos Medical are distributed in USD.

All fundamentals about Avanos Medical

Our stock analysis for Avanos Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avanos Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.